• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New strain of deadly Ebola virus discovered

Shiloh

Editor, Senior Moderator
Source: http://www.google.com/hostednews/afp/article/ALeqM5jERfxrps-i0deW9Rf8IgihdtnOvg

New strain of deadly Ebola virus discovered

PARIS (AFP) ? Scientists said Friday an outbreak of Ebola that killed 37 people in Uganda last year was sparked by a hitherto unknown species of one of the world's most notorious viruses.

The strain -- provisionally named Bundibugyo ebolavirus after the district where the outbreak occurred -- joins four other known species of the pathogen, they said.

More than one in three of patients infected with Bundibugyo died, according to their study, appearing in the US journal PLoS Pathogens, published online by the open-access Public Library of Science (PLoS).


Ebola and the Marburg virus are the two main categories of so-called filovirus which causes haemorrhagic fever (VHF), a disease dubbed a "slate-wiper" for its extreme lethality.

The early signs of VHF are usually a high temperature, exhaustion, dizziness, watery diarrhoea and muscle ache. These symptoms are often mistaken for other fevers, such as flu or yellow fever, because VHF is rare.

As the virus spreads, the feverish patient often starts to bleed under the skin and in severe cases, from the mouth, ears and eyes.

Blood loss, shock and organ failure lead to coma and delirium and, in many cases, to death, within three to seven days after onset of symptoms.

Ebola first came to light in 1976 in Zaire, now the Democratic Republic of Congo (DRC) and is named after the Ebola river with which this outbreak is associated.

Approximately 1,850 cases with over 1,200 deaths have been documented since the virus was discovered, according to the World Health Organisation (WHO).

The deadliest strain, Zaire ebolavirus, inflicts a death rate of 80-90 percent, followed by Sudan ebolavirus, with a mortality of 50-55 percent.

The least harmful are the Cote d'Ivoire ebolavirus, which was discovered in the Ivory Coast in 1994 and so far has caused only a single, non-fatal case of VHF; and the Reston ebolavirus, identified at a US research facility in 1989, which spread from imported lab monkeys to at least four people, none of whom fell sick.

The newly-discovered species came to light after VHF erupted in the townships of Bundibugyo and Kikyo in November 2007, says the study, authored by US and Ugandan doctors.

The US Centers for Disease Control and Prevention (CDC) tested 29 blood samples, which were negative to high-sensitivity tests tailored to the three known strains of Ebola virus. But the samples tested positive in an older, broad-spectrum antibody assay.

Intrigued, investigators pulled apart the pathogen's genetic code to see what they had snared.

Using ultra-fast sequencing technology, they decoded the virus' genome in a matter of days, finding a variation of 32 percent compared with the three existing strains.

Of the 149 suspected cases of Bundibugyo ebolavirus, 37 were fatal, translating into a mortality rate of 36 percent.

The wide genetic divergence between the strains has major implications, the authors say.

It will require the invention of new diagnostic tools to detect outbreaks and could complicate the quest for vaccines and treatments.


US scientists working in a Pentagon-backed programme successfully tested a vaccine among monkeys in 2005 and 2006, but trialling this formula on humans remains a distant goal.

In the absence of a shield or a cure, the only solution is the time-honoured method of isolating the patient, providing barrier protection (rubber gloves, gowns and goggles) for health workers and rigidly observing hygiene procedures.

Ebola is also lethal for non-human primates, killing thousands of gorillas and chimps in recent years and endangering those who butcher or handle their meat.

The natural reservoir for the Zaire ebolavirus has been found in three species of fruitbat in the rainforests of central and western Africa. The wildlife host for the three other strains is unknown.
 
New species of Ebola found in Uganda

New species of Ebola found in Uganda

New species of Ebola found in Uganda

<!-- pgtop -->A new species of Ebola virus has turned up near the foothills of western Uganda. Named Bundibugyo, after a district in the region, the virus resembles no other previously discovered strains ? a feature that might complicate ongoing efforts to develop a universal <XREF REFID="dn7466">vaccine</XREF>.

Based on an outbreak about a year ago, 35% of people infected with Bundibugyo die, says Jonathan Towner, a microbiologist at the US Centers for Disease Control and Prevention in Atlanta, Georgia, who was part of a team that identified the virus.

"If there was a disease spreading in North America with that kind of case fatality that would be a big deal," he says.

Other strains of Ebola previously discovered in Sudan and Zaire can kill more than 90% of people.

When Towner's team received samples of the virus from Uganda, their initial line of tests for previously known Ebola strains turned up negative, he says. "It was clearly Ebola virus, but it was not something we had seen before," he says.
Vaccine hurdle?

Bundibugyo's DNA sequence differs from those of other Ebola viruses by about 32% of its nucleotide letters, Towner's team found. A virus gene important for recognition by our immune system differs by about 25%.

This could be enough to pose problems for vaccines and drugs to treat Ebola, but it is too early to say, Towner says.

That sentiment is echoed by Thomas Geisbert, an Ebola expert at Boston University. "I think it's premature to say that would or wouldn't present a problem for vaccine development," he says.

Towner's team hopes to return to the region and determine the natural reservoir for Bundibugyo virus.

Several species of fruit bats have turned out to be the reservoir for other species of Ebola. "That would be the top of the list," he says.

The unique terrain of the region ? an equatorial mountain range ? could explain why Bundibugyo virus has only produced one outbreak.

"You have a piece of geography that's quite unique," he says. "If the reservoir host is restricted to that type of geography, that sort of niche, that could be reason we've only seen one [outbreak]."

Journal reference: PLoS Pathogens (DOI: 10.1371/journal.ppat.1000212
 
Back
Top